Glycyrrhizic Acid and Its Hydrolyzed Metabolite 18β-Glycyrrhetinic Acid as Specific Ligands for Targeting Nanosystems in the Treatment of Liver Cancer

Glycyrrhizic Acid and Its Hydrolyzed Metabolite 18β-Glycyrrhetinic Acid as Specific Ligands for Targeting Nanosystems in the Treatment of Liver Cancer

Glycyrrhizic acid and its hydrolyzed metabolite 18β-glycyrrhetinic acid, obtained from the plant <i>Glycyrrhiza glabra</i>, have numerous pharmacological activities, such as anti-inflammatory, anti-ulcerative, antiallergic, immunomodulatory, antiviral, antitumor, hepatoprotective, and an...

Full description

Bibliographic Details
Main Authors: Luciano A. Stecanella, Antonio P. R. Bitencourt, Gustavo Richter Vaz, Eride Quarta, José O. C. Silva Júnior, Alessandra Rossi
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Pharmaceutics
Subjects:
glycyrrhizic acid
glycyrrhetinic acid
liver cancer
nanosystems
drug targeting
Online Access:https://www.mdpi.com/1999-4923/13/11/1792

Internet

https://www.mdpi.com/1999-4923/13/11/1792

Similar Items